METODA PENTRU PREVENIREA SI TRATAMENTUL UNEI BOLI ASOCIATA CU ANGIOGENEZA

Price not visible for this package

Interest:

Assignment

Publication info:

No.: RO118566

Date: 30.07.2003

Inventor(s):

MASFERRER JAIME L [US]

RAZ AMIRAM [IL]

Applicant(s):
SEARLE & CO [US]
Classification:
International patent classification (IPC):
A61K31/10; A61K31/18; A61K31/41; A61K31/415; A61K31/4164; A61K31/42; A61K31/425; A61K31/426; A61K31/44; A61K31/4439; A61P1/04; A61P15/00; A61P27/02; A61P3/10; A61P35/04; C07D213/34; C07D231/12; C07D233/64; C07D401/04

Cooperative patent classification (CPC):
A61K31/18 (EP); A61K31/41 (KR); A61K31/415 (EP); A61K31/4164 (EP); A61K31/42 (EP); A61P1/04 (EP); A61P15/00 (EP); A61P27/02 (EP); A61P3/10 (EP); A61P35/00 (EP); A61P35/04 (EP)
Application info:
No.: RO19990000572
Date: 19.11.1997
Priority number(s):
US19960031404P 19.11.1996 ; WO1997US21489 19.11.1997
Related patents:
AU7298298; AU730211; BR9713522; CA2270469; CN1247470; CZ176899; EP0941080; ID21979; IL129604; JP2001505564; KR20000053362; NO992309; NZ335853; PL191793; PL194717; PL333370; RU2268716; SK59999; TR199901703; UA70294; WO9822101
Description:

Inventia se refera la o metoda pentru prevenirea si tratamentul unei boli asociata cu angiogeneza. Metoda pentru prevenirea si tratamentul unei boli asociata cu angiogeneza, conform inventiei, consta in aceea ca se administreaza pe cale orala, intravenoasa, intramusculara, subcutanata, intraperitoneala, o cantitate de 0,1...2000 mg, preferabil 0,5...500 mg, mai preferabil 1...200 mg, in doza zilnica de 0,01...100 mg/kg corp, de 1...4 ori pe zi, dintr-un inhibitor ciclooxigenaza-2, care are un IC50 ciclooxigenaza-2 mai mic de 0,2 uM, un raport de selectivitate al inhibarii ciclooxigenazei-2 fata de inhibareaciclooxigenazei-1 de cel putin 50, mai preferabil de cel putin 100, sau care au IC50 ciclooxigenazei-1 mai mare de 1uM, si mai preferabil 10 uM, selectat dintre un compus cu formula I.